Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Double-blinded Randomized Trial for Genotype Based Personalized Prescription of Nevirapine

NCT00986063 is registered in ClinicalTrials.gov with Surakameth Mahasirimongkol as lead sponsor.

NCT NCT00986063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00986063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Double-blinded Randomized Trial for Genotype Based Personalized Prescription of Nevirapine
Lead sponsor
Surakameth Mahasirimongkol
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2009
Completion date
December 31, 2012
Enrollment
1,200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adverse side effects, aids, hiv, hiv infections, nevirapine induced hepatitis, nevirapine induced rash